Rani Therapeutics Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Rani Therapeutics Holdings generated cash of -$51,236,000, which is less than the previous year. Cash used in financing activities reached the amount of $233,000 last year. Net change in cash is therefore -$21,143,000.
Cash Flow
| 2019 | -26.26M | -1.53M | 852K |
|---|---|---|---|
| 2020 | -14.96M | -1.2M | 72.68M |
| 2021 | -32.24M | -506K | 77.14M |
| 2022 | -46.51M | -72.43M | 29.00M |
| 2023 | -51.23M | 29.86M | 233K |
RANI Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 27.50M | 117.45M | 73.05M | 16.53M | 43.48M |
Operating activities | |||||
Net income | -33.97M | -63.34M | -53.08M | -16.70M | -26.58M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 822K | 548K | 497K | 589K | 564K |
Stock-based compensation expense | 19.00M | 15.78M | 22.59M | 0 | 0 |
| Deferred income tax benefit | 19.00M | 15.78M | 22.59M | 0 | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -595K | 163K | 543K | 933K | -271K |
Cash generated by operating activities | -51.23M | -46.51M | -32.24M | -14.96M | -26.26M |
Investing activities | |||||
Purchases Of Investments | -73.26M | -73.81M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.22M | -1.61M | -506K | -1.2M | -1.58M |
Acquisitions Net | 0 | -851K | 0 | 0 | 49K |
Cash generated by investing activities | 29.86M | -72.43M | -506K | -1.2M | -1.53M |
Financing activities | |||||
Common Stock Issued | 395K | 317K | 73.64M | 71.27M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -162 | -626 | 0 | 0 | 0 |
Repayments of term debt | 0 | 29.57M | -4.56M | -1.41M | 0 |
Cash used in financing activities | 233K | 29.00M | 77.14M | 72.68M | 852K |
Net Change In Cash | -21.14M | -89.94M | 44.39M | 56.52M | -26.94M |
Cash at end of period | 6.36M | 27.50M | 117.45M | 73.05M | 16.53M |
| Data source | Data source | Data source |